David A. Siegel Spectrum Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $375,690 - $751,380	-536,700 Reduced 91.74%	48,300 $38,000
Q1 2022 May 16, 2022	BUY	$0.63 - $1.59 $123,795 - $312,435	196,500 Added 50.58%	585,000 $755,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $133,973 - $255,288	-105,491 Reduced 21.35%	388,500 $493,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $2.17 Million - $3.86 Million	-1,011,300 Reduced 67.18%	493,991 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $504,883 - $777,415	174,700 Added 13.13%	1,505,291 $5.65 Million
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $102,950 - $145,195	35,500 Added 2.74%	1,330,591 $4.34 Million
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $1.73 Million - $2.63 Million	511,900 Added 65.36%	1,295,091 $4.42 Million
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $217,074 - $355,740	72,600 Added 10.22%	783,191 $3.2 Million
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $361,232 - $578,656	171,200 Added 31.74%	710,591 $2.4 Million
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $790,743 - $1.49 Million	432,100 Added 402.74%	539,391 $1.26 Million
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $68,250 - $201,825	-19,500 Reduced 15.38%	107,291 $391,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $17,575 - $24,250	2,500 Added 2.01%	126,791 $1.05 Million
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $277,472 - $424,502	37,700 Added 43.54%	124,291 $1.07 Million
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $282,306 - $368,117	31,091 Added 56.02%	86,591 $926,000
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $262,629 - $698,288	41,100 Added 285.42%	55,500 $486,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $237,888 - $357,408	14,400 New	14,400 $242,000
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $243,270 - $369,750	-17,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $155,928 - $223,571	-9,691 Reduced 36.31%	17,000 $274,000
Q4 2017 Feb 14, 2018	SELL	$13.36 - $20.73 $891,112 - $1.38 Million	-66,700 Reduced 71.42%	26,691 $506,000
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $817,171 - $1.31 Million	93,391	93,391 $1.31 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account